甲磺酸伊马替尼可以通过作用于骨髓微环境来帮助将天然免疫导向抗白血病反应。
Imatinib mesylate can help to direct natural immunity toward an anti-leukemic reactivity by acting on the bone marrow microenvironment.
机构信息
Unit of Molecular Oncology and Angiogenesis; San Martino Hospital-National Institute for Cancer Research; University of Genoa; Genoa, Italy.
出版信息
Oncoimmunology. 2012 Mar 1;1(2):214-216. doi: 10.4161/onci.1.2.18112.
Abstract
We discuss our recent findings on the increase, in chronic myeloid leukemia patients treated with imatinib, of B1 lymphocytes producing IgM anti-O-linked sugars expressed by leukemic cells, paralleled by increased B-stimulating cytokines. We propose that one important effect of imatinib treatment is due to the remodelling of bone marrow microenvironment.
摘要
我们讨论了我们最近在慢性髓性白血病患者中发现的现象，即在接受伊马替尼治疗的患者中，产生 IgM 抗-O 连接糖的 B1 淋巴细胞增加，同时伴有 B 细胞刺激细胞因子增加。我们提出，伊马替尼治疗的一个重要作用是由于骨髓微环境的重塑。
Zotero 插件